OncoMethylome Hopes to Raise $11.3M in Private Placement of New Shares | GenomeWeb
NEW YORK (GenomeWeb News) — OncoMethylome Sciences hopes to raise around €8 million ($11.3 million) or more after issuing a private offering of new shares to institutional and qualified investors, the company said today.
However, the Belgian gene methylation-testing shop said it will not sell more than 10 percent of its outstanding shares.
OncoMethylome said it plans to use the funds to pursue clinical trials for its cancer diagnostics and tests for targeted cancer treatments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.